In the scenerio I spelled out, I didn't have the increase all coming in a matter of days...Q4 numbers out 4/15....Q1 numbers 5/15....if they're good, it'll be worth a bump there.....next in line would be Rx clearance (FDA willing), which should (IMO) push it to .10......if they were to recieve OTC clearance at or around .10, I say it absolutely runs near or over $1....certainly not out of the question.......many stocks with a lot less have done a lot more in pennyland....IMGG ran from .03 to over $1.80...on just an FDA submission , and no revenue....i'm not saying BIEL will recieve clearances on their applications, but I do believe this will run higher than you think if they do...all IMHO...GLTA